Pharmacogenetics
Please click on the test code or test name to obtain a link to the Patient History Form for the desired test.
| Test # | Test Name | Additional Information | Test Keywords | |
|---|---|---|---|---|
| 2013921 | BRAF V600E Mutation Detection in Circulating Cell-Free DNA by Digital Droplet PCR | |||
| 2007228 | 5-Fluorouracil (5-FU) Toxicity and Chemotherapeutic Response, 5 Mutations | 5-Fluorouracil Sensitivity | 5-FU, 5-Fluorouracil Toxicity and Chemotherapeutic Response Panel, Pharmacogenetics (PGx), Colorectal Cancer | |
| 2012166 | Dihydropyrimidine Dehydrogenase (DPYD) Genotyping, 3 Mutations | 5-Fluorouracil Sensitivity | DYPD 5-Fluorouracil toxicity 5-FU toxicity 5-FU toxicity 5FU toxicity Adrucil (DPYD) Genotyping, 3 Mutations Xeloda (capecitabine) (DPYD) Genotyping, 3 Mutations DPD Uftoral (tegafur/uracil) (DPYD) Genotyping, 3 Mutations | |
| 2006102 | ALK Gene Rearrangements in NSCLC for Crizotinib Eligibility by FISH | ALK Gene Rearrangements | ALK GENE, Lung cancer, pharmcogenetics, pulmonary cancer | |
| 2008420 | BCR-ABL1 Mutation Analysis by Next Generation Sequencing | Additional Technical Information | BCR-ABL1 | Chronic Myelogenous Leukemia (CML), Acute Lymphoblastic Leukemia (ALL), Tumor Markers, NGS |
| 2002298 | BCR/ABL1 Fusion t(9;22)(q34;q11.2) by FISH | BCR-ABL1 | ||
| 2002498 | BRAF codon 600 Mutation Detection by Pyrosequencing | BRAF codon 600 | Melanoma, Colorectal cancer, Lynch Syndrome, HNPCC, Hereditary Nonpolyposis Colorectal Cancer, Gastrointestinal Adenocarcinoma, Papillary thyroid carcinoma | |
| 2004247 | CEBPA Mutation Detection | Additional Technical Information | CEBPA Mutation | Acute Myelogenous Leukemia (AML) |
| 0051232 | Cytochrome P450 2D6 (CYP2D6) 14 Mutations and Gene Duplication | Cytochrome P450 | CYP 2D6, Tamoxifen, Pharmacogenetics (PGx), Schizophrenia, Breast Cancer, breast biomarkers | |
| 2012769 | Cytochrome P450 2C19, CYP2C19 - 9 Variants | Cytochrome P450 | CYP2C19, Pharmacogenetics (PGx), Schizophrenia, Breast Cancer, breast biomarkers | |
| 2012766 | Cytochrome P450 2C9, CYP2C9 - 2 Variants | Additional Technical Information | Cytochrome P450 | CYP2C9, Warfarin Sensitivity, Pharmacogenetics (PGx) |
| 2012740 | Cytochrome P450 3A5 Genotyping, CYP3A5, 2 Variants | Cytochrome P450 | ||
| 2013098 | Cytochrome P450 Genotype Panel | Cytochrome P450 | CYP PAN | |
| 0092066 | Thiopurine Methyltransferase, RBC | Additional Technical Information | Drug Therapy | TPMT RBC, Thiopurine Methyltransferase Activity (TPMT), Pharmacogenetics (PGx), Immunosuppressive Drugs, Rheumatoid Arthritis (RA), Inflammatory Bowel Disease (IBD) |
| 2002440 | EGFR Mutation Detection by Pyrosequencing | Additional Technical Information | EGFR Mutation | Lung Cancer |
| 2002674 | Gastrointestinal Stromal Tumor Mutation | Additional Technical Information | Gastrointestinal Stromal Tumors (GIST) | Gastrointestinal Stromal Tumors (GIST) |
| 0080135 | Glucose-6-Phosphate Dehydrogenase | Additional Technical Information | Glucose-6-Phosphate Dehydrogenase | G6PD, Dapsone, Flutamide, Mafenide cream, Methylene blue, Nalidixic acid, Nitrofurantoin, Phenazopyridine, Primaquine, Rasburicase, Sulfacetamide, Sulfamethoxazole, Sulfanilamide |
| 2012049 | HLA-B*15:02 Genotyping, Carbamazepine Hypersensitivity | HLA-B*15:02 (Carbamazepine Hypersensitivity) Genotyping | ||
| 2002429 | HLA-B*5701 Associated Variant Genotyping for Abacavir Sensitivity | HLA-B*5701 (Abacavir Sensitivity) Genotyping | HLA-B5701, Pharmacogenetics (PGx), HIV Drug Resistance, HIV, Abacavir sensitivity, Ziagene, Abacavir hypersensitivity, ABC HSR | |
| 2004680 | Interleukin 28 B (IL28B)—Associated Variants, 2SNPs | Interleukin 28 B Associated SNP—Genotyping | IL28B, Hepatitis C Virus (HCV), peginterferon, interferon, PEG-IFNα | |
| 2002357 | JAK2 Exon 12 Mutation Analysis by PCR | Additional Technical Information | JAK2 Gene | Myeloproliferative Neoplasms (MPN), Tumor Markers |
| 0051245 | JAK2 Gene, V617F Mutation, Qualitative | Additional Technical Information | JAK2 Gene | Myeloproliferative Neoplasms (MPN), Tumor Markers |
| 0040168 | JAK2 Gene, V617F Mutation, Quantitation | Additional Technical Information | JAK2 Gene | Myeloproliferative Neoplasms (MPN), Tumor Markers |
| 2002695 | KIT Mutations, Melanoma | Additional Technical Information | KIT Mutation | Melanoma, Tumor Markers, C-KIT, CKIT |
| 0040248 | KRAS Mutation Detection | Additional Technical Information | KRAS Mutation | Pharmacogenetics (PGx), Lung Cancer, Colorectal Cancer, Tumor Markers, CRC, colon, rectal |
| 2001932 | KRAS Mutation Detection with BRAF reflex | Additional Technical Information | KRAS Mutation | Pharmacogenetics (PGx), Lung Cancer, Colorectal Cancer, Tumor Markers, CRC, colon, rectal |
| 0055655 | Methylenetetrahydrofolate Reductase (MTHFR) 2 Mutations | Methylenetetrahydrofolate Reductase (MTHFR) | MTHFR PCR, Thrombophilia, methotrexate sensitivity, cardiovascular, C677T, A1298C | |
| 2003123 | NRAS Mutation Detection by Pyrosequencing | Additional Technical Information | NRAS Mutation | Colorectal, melanoma, Hereditary Nonpolyposis Colorectal Cancer , HNPCC, Tumor Markers, CRC, colon, rectal |
| 2002363 | PML/RARα Translocation by FISH | Oncology Studies, FISH—Blood and Bone Marrow Panels | FISH PML, Acute Myeloid Leukemia (AML), Acute Promyelocytic Leukemia (APL), Tumor Markers | |
| 2008603 | ERBB2 (HER-2/neu) Gene Amplification by FISH, Tissue | Oncology Studies, FISH—Paraffin Block | HER2FISH, Breast Cancer, Tumor Markers, FISH, herceptin, HER2, HER-2, neu, HER2/neu, pathvision, pathvysion | |
| 2008767 | Opioid Receptor, Mu (OPRM1) Genotype, 1 Variant | Additional Technical Information | Opioid Receptor, Mu | OPRM1, opioid receptor, mu, mu receptor, naltrexone, opioid dependency, alcoholism |
| 2002298 | PDGFRα Rearrangement | PDGFRα/β Rearrangements | ||
| 2002298 | PDGFRβ Rearrangement | PDGFRα/β Rearrangements | ||
| 2002871 | PML-RARA Translocation, t(15;17) by RT-PCR, Quantitative | Additional Technical Information | PML-RARA Translocation | Acute Myelogenous Leukemia (AML), Acute Promyelocytic Leukemia (APL) |
| 2008426 | Statin Sensitivity (SLCO1B1), 1 Variant | Statin Sensitivity | SLCO1B1, stimvastatin, Solute Carrier Organic Anion Transporter Family Member 1B1, rs4149056C, SLCO1B1*5, OATP1B1, organic anion-transporter polypeptide 1B1 | |
| 2012233 | Thiopurine Methyltransferase (TPMT) Genotyping, 4 Variants | Additional Technical Information | Thiopurine Methyltransferase | TPMT DNA 6-mercaptopurine 6-MP 6MP toxicity 6-thioguanine 6-TG 6TG AZA toxicity Azathioprine S-adenosyl-L-methionine genotype Thioguanine Thiopurine S-Methyltransferase genotype Thiopurine TPMT mutation TPMT gene TPMT genetics |
| 0092066 | Thiopurine Methyltransferase, RBC | Additional Technical Information | Thiopurine Methyltransferase | TPMT RBC, Thiopurine Methyltransferase Activity (TPMT), Pharmacogenetics (PGx), Immunosuppressive Drugs, Rheumatoid Arthritis (RA), Inflammatory Bowel Disease (IBD) |
| 0051332 | UDP Glucuronosyltransferase 1A1 (UGT1A1) Genotyping | UGT1A1 Genotyping | UGT1A1, Irinotecan, Pharmacogenetics (PGx), Colorectal Cancer | |
| 2012772 | Warfarin Sensitivity, CYP2C9 & VKORC1, 3 Variants | Additional Technical Information | Warfarin Genotyping | WARF GENO, Warfarin metabolism, Coumadin, Pharmacogenetics (PGx), cytochrome P450 2C9, CYP2C9*2, CYP2C9*3, c.-1639G>A |